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Abstract
Controlling translation is crucial for the homeostasis of a cell. Its deregulation can facilitate the development and
progression of many diseases including cancer. Poly (A) binding protein interacting protein 2 (Paip2) inhibits efficient
initiation of translation by impairing formation of the necessary closed loop of mRNA. The over production of Paip2 in the
presence of a constitutively active form of hRas
V12 can reduce colony formation in a semi-solid matrix and focus formation
on a cell monolayer. The ability of Paip2 to bind to Pabp is required to suppress the transformed phenotype mediated by
hRas
V12. These observations indicate that Paip2 is able to function as a tumor suppressor.
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Introduction
Uncontrolled cell growth, the loss of contact inhibition and the
ability of cells to grow in semi-solid matrix are all characteristics of
transformed cells and the beginning of oncogenesis. These
processes are dependent upon cell metabolism. Regulation of
protein synthesis, a critical component of cell metabolism, is a
critical component of cellular transformation and oncogenesis.
The cell regulates protein synthesis at many different steps,
such as initiation of translation by a variety of mechanisms. One
mean governs the recruitment of the ribosome, and the proteins
required for initiation of translation to the RNA. Formation of
the closed loop of mRNA is necessary for efficient translation
initiation is also another point of regulation. The circularization
of the mRNA brings together of the 59-a n d3 9-ends of the
mRNA. Several initiation proteins, and the poly (A) tail, a stretch
of adenosine residues that varies in length found at the 39-end of
the most eukaryotic mRNAs, mediate formation of the closed
loop. The eukaryotic initiation factor (eIF) complex 4F binds the
59-end of the mRNA. Three proteins, eIF4E, the cap binding
protein, eIF4G, a large scaffolding protein and the RNA
bidirectional DEAD-box helicase eIF4A make up this complex.
Within the amino-terminus (N-) of eIF4G is the binding site for
eIF4E; thus, the complex is tethered to the 59-end of the mRNA.
The binding site for poly (A) binding protein (Pabp) lies within
this region of eIF4G as well [1]. Papb also binds the poly (A) tail
of the mRNA. Hence the interaction between eIF4E-eIF4G-Pabp
links the two ends of the mRNA together, generating the closed
loop [2,3].
Two proteins, poly (A) binding protein interaction protein
(Paip) 1 and 2, regulate the interaction between Pabp and the
poly (A) tail, and Pabp and eIF4G [4,5]. Although Paip1 and
Paip2 are very similar including the Pabp interacting motifs
(Pam) domains that bind Pabp between RNA recognition motifs
(RRM) 2 and 3 and the Pabc domain found its carboxy terminus
[6,7], they have opposing functions. By interacting with Papb,
eIF4A and eIF3, the initiation factor that binds the small
ribosomal subunit bind and the central domain of eIF4G, aiding
in the recruitment of the ribosome to the 59-end of the mRNA,
Paip1 is believed to stimulate translation in cultured cells [4,8].
Paip2, in constrast, disrupts the closed loop of RNA necessary for
efficient initiation. By directly binding Pabp, Paip2 facilitiates the
dissociation of Pabp from the poly (A) tail, interrupts the Pabp-
eIF4G interaction and prevents free Pabp in the cytoplasm from
binding to poly (A) RNA [9]. Paip2 is therefore a negative
regulator of protein synthesis.
The de-regulation and over production of many proteins
involved in mRNA translation such as eIF4E has been
implicated in cellular transformation and oncogenesis
[10,11,12]. Although Papb is a highly abundant protein in the
cytosol of the cell, its over production has also been correlated
with the development of preleukemic thymuses in mice and
gastrointestinal tumors in humans [13,14]. Because it is a
negative regulator of Pabp activity and of protein synthesis,
Paip2 can therefore function as inhibitor of cellular transforma-
tion and a tumor suppressor.
Results
Understanding the biological function of proteins can be
investigated either by deleting the encoding gene or by the over
production of the protein. To decipher how Paip2 alters the
biology of the cell, the protein was over produced in NIH3T3 cells
(Fig. 1A). Increased production of Paip2 did not significantly alter
the growth properties of these cells as determined by flow
cytometry. However, entry into the G1/S transition was delayed
for several hours when cells synchronized by serum starvation
were released from growth arrest (Fig. 1B). This observation
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protein products are necessary for the G1/S transition and correct
control of the cell cycle.
Many proteins that govern progression through the cell cycle
function either as oncogenes, by either promoting progression
through the cycle or as tumor suppressors by restricting
progression through the cell cycle. Therefore it is possible that
Paip2 may function as a tumor suppressor as over production of
the protein delays progression through the cell cycle. Paip2 was
introduced into NIH3T3 cells producing a constitutively active
form of ras, hRas
V12 and assayed for the ability to form foci on a
monolayer and growth in soft agar. Increased levels of Paip2
impeded the ability of hRas
V12 producing cells from growing in
soft agar and forming foci on a monolayer (Fig. 2A & B). These
data suggest that Paip2 can function to inhibit cellular transforma-
tion.
Figure 1. Cell cycle analysis of NIH 3T3 cells over producing Paip2. A. Western blot analysis of NIH3T3 cells alone, or infected with a
retrovirus encoding for HA-Paip2 or HA-Paip2, 9As using anti-Paip2 antibody. B. Flow cytometry analysis demonstrating the 3-hour delay of entry into
the cell cycle by BrUd staining of NIH3T3 producing wild type HA-Paip2 after the addition of serum following 72 hours of starvation.
doi:10.1371/journal.pone.0025116.g001
A Novel Tumor Suppressor, Paip2
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e25116Aberrant regulation of protein synthesis has been implicated in
the development and progression of cancer. Paip2 was initially
identified as directly interacting with the initiation factor Pabp and
impairing its ability to facilitate formation of the closed loop of
mRNA necessary for efficient translation. The Pam domains,
Pabp interaction motifs 1 and 2 within Paip2 have been
described as mediating the Pabp-Paip2 interaction. However
only the Pam2 domain is required for repression of translation
by Paip2. It is believed that a series of glutamic acid residues
within this region is required Pabp-Paip2 interaction (Fig. 3).
Alteration of these glutamic acid residues to alanines not only
impaired the Pabp-Paip2 interaction but it also partially
ameliorated the ability of Paip2 to retard cellular transformation
by hRas
V12 ( F i g .2 A& B ) .T h e r e f o r et h ea b i l i t yo fP a i p 2t o
function as a tumor suppressor is dependent upon its ability to
interact with Pabp.
Discussion
Protein synthesis is critical to normal cell survival. Its de-
regulation facilitates the development of many diseases including
cancer. Therefore, any protein that modulates mRNA translation
may function as either an oncogene or a tumor suppressor. Paip2
is a translation repressor. It inhibits translation initiation by
promoting dissociation of Pabp from the poly (A) tail and eIF4G,
and by preventing free Pabp from interacting with eIF4G, thereby
disrupting formation of the closed loop of mRNA necessary to
efficiently initiate translation. Alteration of the glutamic acids in
Figure 2. Paip2 impedes cellular transformation by hRas
V12. A. Formation of cell focus by NIH3T3 cells producing hRas
V12 and HA-Paip2 or
HA-Paip2, 9As on a monolayer of NIH3T3cells. B. Impairment of anchorage independent cell growth of NIH3T3 cells producing hRas
V12 by HA-Paip2.
doi:10.1371/journal.pone.0025116.g002
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over production of wild type Paip2 suppresses cellular transforma-
tion mediated by the oncogene hRas
V12. The over production of
Paip2 in NIH 3T3 cells producing hRas
V12 resulted in formation
of fewer colonies in soft agar, and reduced formation of foci on
monolayers. Moverover, the G1/M transition of cells that over
produced Paip2 was delayed by several hours. These data are
consistent with the observation that enhanced levels of Paip2 in
Drosophila melanogaster also influences cell growth and proliferation.
The over-production of dPaip2 impairs cell proliferation but not
cell size in mitotically dividing cells of the wing disc. However, in
non-dividiving cells of the eye and larval fat body, elevated levels
of dPaip2 reduce cell size but not cell number [15]. These
observations are similar to the phenotype of flies lacking the cell
cycle regulator Cdk4 [16] and lead to the suggestion that the
translation of the cdk4 encoding mRNA may be specifically
sensitive to the intracellular concentration of dPaip2. Since, Paip2
is a phylogenetically conserved protein from flies to human, and
functions as an inhibitor of translation initiation throughout
evolution, it may be possible that translation of mRNAs responsive
to the concentration of Paip2 would also be evolutionarily
conserved. Identification of mRNAs whose translation is effected
by the intracellular concentration of Paip2 should enhance our
understanding of how mRNA translation regulates cell prolifera-
tion.
Formation of the closed loop of mRNA necessary for efficient
translation initiation can be regulated at both the 59-end and the
39-end of the RNA. The translation inhibitors, eIF4E binding
proteins (4E-BPs) prevent formation of the eIF4F complex at the
59-end of the mRNA by preventing the eIF4G-eIF4E interaction
[17,18]. The serine-threonine kinase mammalian target of
rapamycin (mTOR) regulates their activity [19]. The mRNAs
whose translation is specifically sensitive to the intracellular
concentration of the 4E-BPs and eIF4E have been well
characterized, and include cyclin D1 [20,21,22,23]. The 59-end
of these mRNAs is thought to contain stable secondary structures.
Recruitment and scanning of the ribosome is therefore believed to
be highly dependent upon eIF4E. It is possible that translation of
this same population of mRNAs is regulated from the 39-end by
the Paip2-Pabp interaction. Translation of a different subset of
RNAs, including those encoding Cdk4 and other proteins that
regulate cell growth and proliferation, are more likely to be
modulated by the Paip2-Pabp interaction. Neither Paip2 nor Pabp
are regulated by mTOR and the aberrant activation of many
different signaling cascades can result in cellular transformation.
Identification of mRNAs whose translation is effected by the
intracellular concentration of Paip2 should enhance our under-
standing of how mRNA translation regulates cell proliferation.
Previous work has demonstrated that the concentration of Paip2
within the cell is mediated by its interaction with Pabp. When not
bound to Pabp, Paip2 can be targeted to the proteosome for
degradation by ubiquitination by the E3 ligase EDD1. Activity of
EDD1 is cell cycle regulated; it is high during G1/S and low
during mitosis, suggesting that the level of Paip2 would be higher
during mitosis than G1/S. Higher levels of Paip2 during mitosis
may lead to in the dramatic reduction of 59-end dependent
initiation known to occur during this phase of the cell cycle.
Aberrant degradation of Paip2 may lead to a higher concentration
of free Pabp within the cytoplasm. Increased levels of Pabp
correlate with the development of several cancers [13,14].
Moreover, elevated levels of EDD1 have been observed in several
tumors including breast, and ovarian [24]. The mechanism
directly regulating degradation of Paip2 by EDD1 remains elusive.
Activity of EDD1, however, is regulated by ERK2, a component
of extracellular signal-regulated kinase pathway, in the presence of
epidermal growth factor (EGF) [25]. Proteins such as B-RAF and
Ras, known oncogenes, are known to regulate ERK2 activity.
Thus it may be possible that ubiquitination of Paip2 by EDD1
may occur both in response to the presence of different growth
factors and cytokines that stimulate ERK2 activity and also in cells
in which B-Raf and Ras are constitutively active. Continued
understanding how of the interactions of Paip2 and Pabp, and of
Paip2 and EDD1 are regulated should augment our under-
standing of how efficient translation initiation is controlled and
promote the development of novel anti-cancer therapeutic agents.
Materials and Methods
Cells and plasmids
NIH3T3 cells were grown in Dulbecco’s modified Eagle
medium (Sigma) 10% bovine calf serum (Invitrogen) and 1%
penicillin-streptomycin (Invitrogen). Selection of NIH3T3 cells
stably expressing hRas
V12 was maintained by the addition of
puromycin at every passage. NIH3T3 cells stably expressing
murine HA-Paip2 or HA-Paip2 (9A) were grown in the presence
of hygromycin. NIH3T3 cells stably producing HRas
V12 and HA-
Paip2 or HA-Paip2 (9A) were maintained by the addition of
puromycin and hygromycin at every passage. Phoenix-293-T cells
were grown in Dulbecco’s modified Eagle medium, 10% fetal calf
serum and (Invitrogen) and 1% penicillin-streptomycin (Invitro-
gen). Plasmids p-BABE hRas
V12 and pWzl were generous gifts of
Scott Lowe, Cold Spring Harbor Laboratory, NY.
Generation of stable cell lines
Cell lines over producing of hRas
V12, HA-Paip2 and HA-Paip2
(9A) were generated by introducing the appropriate encoding
plasmid into phoenix-293-T cells by calcium phosphate transfec-
tion. Viruses were harvested 48 hours post-transfection and
filtered (0.45 mm-pore-size filter). NIH3T3 cells were infected
with the appropriate virus or viruses and 48 hours postinfection
were selected by the addition of puromycin, hygromycin or
puromycin and hygromycin. Production of hRas
V12, HA-Paip2
and HA-Paip2 (9A) was confirmed by Western blot analysis.
Co-immunoprecipation and western blot analysis
Cells were collected following stimulation and lysed in cold
buffer containing 20 mM Tris-HCl (pH 7.5), 0.1 mM EDTA,
1 mM DTT, 100 mM KCl, and 10% glycerol (v/v), and a
Figure 3. The Pam2 domain is required for the Paip2-Pabp
interaction. Demonstration of the requirement for the Pam 2 domain
of Paip2 for the Pabp-Paip2 interaction by immunoprecipation of HA-
Paip2 or HA-Paip2, 9As from NIH3T3 cells by anti-HA antibody and
Western blot analysis of cell lysates.
doi:10.1371/journal.pone.0025116.g003
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was determined using the Bio-Rad Protein Assay (Mississauga,
ON, Canada). Cellular extracts (1 mg of protein) were incubated
end-over-end with 50% slurry of protein G-sepharose for 1 hour
at 4uC, and with mouse monoclonal anti-HAII antibody overnight
at 4uC. The mixture was centrifuged at 3000 rpm for 30 seconds
and the resin was washed three times in 0.5 ml of the above buffer.
Proteins were eluted with 26Laemmli sample buffer and resolved
by 15% SDS-PAGE. The separated proteins transferred onto a
nitrocellulose membrane (Protran, Perkin-Elmer). Membranes
were incubated at room temperature in 5% nonfat milk dissolved
in blot buffer (10 mM Tris, pH 7.5, 150 mM NaCl, 0.05% Tween
20) for 1 hour and incubated at 4uC overnight with one of the
following specific antibodies: anti-HAII, anti-Pabp and anti-b-
actin was from Sigma-Aldrich. Proteins were then detected with
anti-mouse (sheep) or anti-rabbit (donkey) IgG horseradish
peroxidase-linked antibodies (GE Healthcare, Baie d’Urfe, QC,
Canada) and subsequent visualization by Western Lightning-
chemiluminescent substrate system (Perkin Elmer).
Cell cycle analysis
NIH3T3 cells and NIH3T3 cells producing HA-Paip2 and HA-
Paip2 (9A) were grown to 40% confluency in presence 10% bovine
calf serum. Cells were washed twice with 16PBS and grown for
72 hours in presence of 0.1% bovine calf serum in order to
synchronchrous their position within the cell cycle. Cells were
harvested at various time after the addition of medium containing
10% bovine calf serum, washed twice in cold 16 PBS, fixed in
ethanol, stained with prodium iodine, and analyzed by flow
cytometry.
Cell transformation assays
Soft agar assays. Approximately 5610
4 cells were
resuspened in 2.5 ml of 0.35% (wt/vol) agar solution, containing
DMEM plus 20% BCS and onto a 0.5% (wt/vol) agar solution
containing DMEM plus 20% BCS in a 60-mm plate. 2 days after
incubation, 3 ml of DMEM supplemented with 20%BCS was
added. Colonies were counted 21 days after plating.
Focus formation on a cell monolayer. NIH3T3 cells stably
producing HRas
V12 and HA-Paip2 or HA-Paip2 (9A) were on a
monolayer of NIH3T3 in 1000:1 ratio for 28 days. Foci were fixed
in methanol and stained by methylene blue.
All data are the mean 6 the standard of error of the mean from
three independent experiments.
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